NCT05260554

Brief Summary

In this study, we will try to emphasize the effects of using cranberry tablets, which is an alternative to antibiotic therapy, during uncomplicated urinary tract infections (only urinary tract, bladder and kidney infections did not).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 26, 2022

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

February 18, 2022

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 18, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 18, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 2, 2022

Completed
Last Updated

March 2, 2022

Status Verified

February 1, 2022

Enrollment Period

23 days

First QC Date

February 18, 2022

Last Update Submit

February 18, 2022

Conditions

Keywords

Urinary Tract DiseaseCranberry extractAntibioticCystitis

Outcome Measures

Primary Outcomes (1)

  • Treatment time

    After 7 days of treatment, the 2 treatment options were compared with each other.

    7 days

Study Arms (2)

using fosfomycin

The patients in this group; have been prescribed fosfomycin for 7 days (3 doses, two days apart).

Drug: Fosfomycin

using cranberry extract

The patients in this group; took 7 days (1 tablet each day) of cranberry tablets.

Dietary Supplement: Cranberry

Interventions

In this group with urinary tract inflammation; Fosfomycin was prescribed for 7 days (3 doses, 2 days apart). There are 80 patients in total.

Also known as: monurol
using fosfomycin
CranberryDIETARY_SUPPLEMENT

In this group with urinary tract inflammation; 7 days (used every day) cranberry tablet was given. There are 80 patients in total.

using cranberry extract

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Among the patients who were eligible criteria, the study was terminated when the number of patients in both groups reached 80.

You may qualify if:

  • Older than 18
  • who have urinary tract inflammation
  • who haven't kidney dissease previous

You may not qualify if:

  • Younger than 18
  • Who have kidney inflammation
  • Pregnant patients
  • Who have blood test abnormal (WBC, Ure, Creatin, CRP high level)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oya Guven, MD

Kırklareli, Center, 39000, Turkey (Türkiye)

Location

Related Publications (1)

  • Gray M. Are cranberry juice or cranberry products effective in the prevention or management of urinary tract infection? J Wound Ostomy Continence Nurs. 2002 May;29(3):122-6. doi: 10.1067/mjw.2002.124016. No abstract available.

MeSH Terms

Conditions

Urologic DiseasesCystitis

Interventions

Fosfomycin

Condition Hierarchy (Ancestors)

Female Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesUrinary Bladder Diseases

Intervention Hierarchy (Ancestors)

OrganophosphonatesOrganophosphorus CompoundsOrganic Chemicals

Study Officials

  • Oya Guven

    Kırklareli University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 18, 2022

First Posted

March 2, 2022

Study Start

January 26, 2022

Primary Completion

February 18, 2022

Study Completion

February 18, 2022

Last Updated

March 2, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

The data results of the patients will be described in the article.

Locations